Eisai Accelerates Progress in Oncology Research with New Data at ESMO Congress 2024
TOKYO, Sept 5, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. announced today the presentation of research across various types of cancer from its oncology portfolio and pipeline during the European Society for Medical Oncology (ESMO) Congress 2024,
More